Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)Neovascular Age-related Macular Degeneration; nAMDActive, not recruitingPhase 32026-09-01NCT05562947

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Hoffmann-La Roche280

14 results · Page 1 of 1

Swipe the table sideways for more columns.